Uploaded February 2026 | Updated November 2026, 20 hours ago
Have you or someone in your circle received IVIg or ScIg? If so, then you may know that there is a period of flare-up for a few days. It could be so severe that it prevents the patient from receiving the full dose. Dr. Jones an immunologist and his colleague has found a groundbreaking method to reduce these side-effects. This will result in enabling a lot of patients for receiving their medication.
Join me today to review a case study that Dr. Jones (Immunologist) et. al., recently published. In this report
How to find Dr. Jones:
Study
Managing Primary Immunodeficiency Immunoglobulin Replacement Therapy‐Related Adverse Events With Recombinant Human C1 Esterase Inhibitor Prophylaxis: A Case Report - PMC
pmc.ncbi.nlm.nih.gov/articles/PMC12875838
Instagram
instagram.com/p/DUi9mhpDvox
Clinic:
GAIN | Food Allergy Freedom Starts Here
myimmunenetwork.com
💙 Want to support this work?
☕ Buy me a coffee: buymeacoffee.com/DrMobeenSyed
🎥 Become a patron: patreon.com/mobeensyed?fan_landing=true
💵 PayPal: paypal.me/mobeensyed?locale.x=en_US
📬 My Substack: mobeensyedmd.substack.com
🛑 Medical Disclaimer:
This video is not intended to provide assessment, diagnosis, treatment, or medical advice; it also does not constitute provision of healthcare services. The content provided in this video is for informational and educational purposes only.
Please consult with a physician or healthcare professional regarding any medical or mental health-related diagnosis or treatment. No information in this video should ever be considered as a substitute for advice from a healthcare professional.
Have you or someone in your circle received IVIg or ScIg? If so, then you may know that there is a period of flare-up for a few days. It could be so severe that it prevents the patient from receiving the full dose. Dr. Jones an immunologist and his colleague has found a groundbreaking method to reduce these side-effects. This will result in enabling a lot of patients for receiving their medication.
Join me today to review a case study that Dr. Jones (Immunologist) et. al., recently published. In this report
How to find Dr. Jones:
Study
Managing Primary Immunodeficiency Immunoglobulin Replacement Therapy‐Related Adverse Events With Recombinant Human C1 Esterase Inhibitor Prophylaxis: A Case Report - PMC
pmc.ncbi.nlm.nih.gov/articles/PMC12875838
instagram.com/p/DUi9mhpDvox
Clinic:
GAIN | Food Allergy Freedom Starts Here
myimmunenetwork.com
💙 Want to support this work?
☕ Buy me a coffee: buymeacoffee.com/DrMobeenSyed
🎥 Become a patron: patreon.com/mobeensyed?fan_landing=true
💵 PayPal: paypal.me/mobeensyed?locale.x=en_US
📬 My Substack: mobeensyedmd.substack.com
🛑 Medical Disclaimer:
This video is not intended to provide assessment, diagnosis, treatment, or medical advice; it also does not constitute provision of healthcare services. The content provided in this video is for informational and educational purposes only.
Please consult with a physician or healthcare professional regarding any medical or mental health-related diagnosis or treatment. No information in this video should ever be considered as a substitute for advice from a healthcare professional.










